Slightly elevated CD276 scores in benigne samples from early-stage BC tumor patients could be caused by a moderate activation of CD276 expression in a few cells surrounding the tumor without showing the typical histology of a BC tumor by microscopy. The gene discussed is CD276; the disease is breast cancer.